Myomo, Inc. (MYO)

USD 5.63

(-6.17%)

Market Cap (In USD)

187.17 Million

Revenue (In USD)

19.24 Million

Net Income (In USD)

-8.14 Million

Avg. Volume

449.35 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.511-6.745
PE
-
EPS
-
Beta Value
1.555
ISIN
US62857J2015
CUSIP
62857J201
CIK
1369290
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Paul R. Gudonis
Employee Count
-
Website
https://www.myomo.com
Ipo Date
2017-06-12
Details
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

More Stocks